Newsletter
8 de February de 2022
News on apostille of letters-patent retroactively affected by the Direct Plea of Unconstitutionality 5,529
On February 8th, 2022, the Brazilian Patent Office reported the decision to apostille letters-patent when the patent protects subject-matter going beyond the limits of the pharmaceutical area and/or health products/equipment for application in humans.
When the patent concomitantly encompasses subject-matter related to the pharmaceutical area and/or health products/equipment for application in humans and others not related to these technical areas, the apostille will take place as follows:
- For patents granted with the 10-year term counted as from their granting, the BPTO will maintain this term of protection, except for the subject-matter related to the pharmaceutical area and/or health products/equipment for use in humans, term of which will be 20 years counted as from their filing date;
. - The letter-patent will be rectified to include the apostille through the publication of the dispatch 16.3;
.. - The BPTO will produce an internal document justifying the rectification made. Said document will not be made publicly available, but it may be provided to interested parties upon request to the BPTO;
. - The extinction will be published taking into account the longest patent term, albeit part of the subject-matter related to pharmaceutical products and health products/equipment for application in humans will have its extinction before this date, as apostilled in the letter-patent;
. - Annuities must be paid considering the longest patent term.
.
In case you need further information on this topic, we are at your disposal by means of email: mail@kasznarleonardos.com.
Last related news
25 de November de 2025
Significant Win for Kasznar Leonardos as Appellate Court Raises Compensation in Software Infringement Case
Kasznar Leonardos is pleased to announce an important victory before the São Paulo Court of Appeals in a software license compliance action … Significant Win for Kasznar Leonardos as Appellate Court Raises Compensation in Software Infringement Case
13 de November de 2025
ANVISA Publishes Exceptional Rule to Expedite Analysis of Medicines and Biological Products
The National Health Surveillance Agency (Anvisa) published on Monday, November 10, 2025, the Collegiate Board Resolution (RDC) No. 997/2025, which institutes exceptional … ANVISA Publishes Exceptional Rule to Expedite Analysis of Medicines and Biological Products
4 de November de 2025
ANVISA Publishes New Proposal for Review of the Regulation on General Labeling of Packaged Foods: Public Consultation No. 1357/2025
The proposal for reviewing the regulation concerning the general labeling of packaged foods (including beverages, ingredients, additives, and processing aids) was published … ANVISA Publishes New Proposal for Review of the Regulation on General Labeling of Packaged Foods: Public Consultation No. 1357/2025